Point72 Hong Kong’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Point72 Hong Kong’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,667	Closed	-$219K	–	2525
2022 Q1	$219K	Buy	+2,667	New	+$273K	0.01%	941
2021 Q3	–	Sell	-6,997	Closed	-$1.13M	–	2552
2021 Q2	$1.13M	Buy	6,997 +6,755	+2,791%	+$1.08M	0.04%	667
2021 Q1	$41K	Sell	242 -67	-22%	-$13.3K	﹤0.01%	1325
2020 Q4	$68K	Buy	+309	New	+$66.8K	﹤0.01%	1151
2020 Q3	–	Sell	-838	Closed	-$96K	–	1615
2020 Q2	$96K	Buy	+838	New	+$81.3K	0.01%	636
2019 Q4	–	Sell	-146	Closed	-$11K	–	1518
2019 Q3	$11K	Buy	+146	New	+$13.7K	﹤0.01%	754
2018 Q4	–	Sell	-34	Closed	-$2K	–	1277
2018 Q3	$2K	Buy	+34	New	+$1.89K	﹤0.01%	789

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Hong Kong's MRTX Position: Q2 2022 in Review

Point72 Hong Kong sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2022, closing a stake of 2,667 shares — an estimated $219K sold.

Point72 Hong Kong first reported a position in MRTX in Q3 2018 and held it in 7 quarters. The position peaked at $1.13M in Q2 2021. 230 funds tracked by Wall St. Rank hold MRTX as of Q2 2022.

Point72 Hong Kong reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 2,667 Mirati Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $219K.
Point72 Hong Kong first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
Point72 Hong Kong's Mirati Therapeutics, Inc. Common Stock position peaked at $1.13M in Q2 2021.
230 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.